Arvaya Healthcare CEO, MD, chairman, board of directors and AGM
BSE: 524723Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹100.75.
- The board meets on 24 Oct 2026.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹493 Cr2,703rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 3 Jun 2026
- 8.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −3.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 3 Jun 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 86
Arvaya Healthcare board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorKAUSHAL UTTAM SHAH
- Chief executiveSALIL SRIRAM SHETTY
5 directors3 independent2 executive
- KAUSHAL UTTAM SHAH · Chairperson and managing directorExecutive · joined May 2025 · reappointed Jul 2025 · 60 months as independent · 2 listed boards · 3 committee seats
- SALIL SRIRAM SHETTY · Chief executiveExecutive · joined Aug 2024 · reappointed Apr 2026 · 60 months as independent · 1 listed board
- RAHUL RAVINDRA MAYURIndependent · joined Jul 2025 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- BIJESH JUGALKISHOR BIYANIIndependent · joined Jul 2025 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- MANALI ADITYA PANDITIndependent · joined Jan 2026 · 60 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 28 May 20265 of 5 present3 independent · 71 days in between
- 17 Mar 20265 of 5 present3 independent
Audit Committee
Chair RAHUL RAVINDRA MAYUR
BIJESH JUGALKISHOR BIYANI, KAUSHAL UTTAM SHAH
- 28 May 20263 of 3 present2 independent · 71 days in between
- 17 Mar 20263 of 3 present2 independent
Nomination and remuneration committee
Chair BRIJESH JUGALKISHOR BIYANI
RAHUL RAVINDRA MAYUR, SALIL SRIRAM SHETTY
- 28 May 20263 of 3 present2 independent · 71 days in between
- 17 Mar 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair BRIJESH JUGALKISHOR BIYANI
RAHUL RAVINDRA MAYUR, KAUSHAL UTTAM SHAH
No meeting listed in the filing.
THOSE CHARGED WITH GOVERNANCE
Chair RAHUL RAVINDRA MAYUR
BIJESH JUGALKISHOR BIYANI, KAUSHAL UTTAM SHAH
- 30 Apr 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- KHIRE KHANDEKAR AND KIRLOSKAR CHARTERED ACCOUNTANTSPeer-review certificate valid to Feb 2027
1 earlier auditor
- Rajesh Surana & Co.Named in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Arvaya Healthcare AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Arvaya Healthcare share news and announcements
Annual general meeting, 21 Sep 2026
3,492 shareholders on the register on 14 Sep 2026; present: 3 promoters and 19 others; votes counted by CHINMAY LELE / CHINMAY LELE.The company's voting result (opens in a new tab)
- To receive consider and adopt Standalone Financial Statement of the Company for the Financial Year ended 31st March 2026 and the reports of theBoard of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 68.32% · promoters 100.00% · institutions 0.00% · other public 54.34%
- To receive consider and adopt Audited Consolidated Financial Statements of the Company for the Financial Year ended 31st March 2026 and the reports of the Auditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 68.32% · promoters 100.00% · institutions 0.00% · other public 54.34%
- To consider appointment of Mr. Kaushal Uttam Shah (DIN 02175130) Managing Director of the company who retires by rotation and being eligible offers himself for re appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 68.32% · promoters 100.00% · institutions 0.00% · other public 54.34%
- To consider and approve Material Related Party Transaction (S) Under Section 188 Of The Companies Act 2013 And Regulation 23 Of The Sebi (Listing Obligations And Disclosure Requirements) 2015OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 34.12% · promoters 0.00% · institutions 0.00% · other public 49.17%
- To consider and approve the Material Related Party Transaction for acquisition of the Copyright and Intellectual Property Portfolio of DEFIB Institute of Health Solutions LLPOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 34.12% · promoters 0.00% · institutions 0.00% · other public 49.17%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 13 Aug 2026, 6 resolutions
3,416 shareholders on the register on 10 Jul 2026; votes counted by Mr. Chinmay Mohan Lele / NA.The company's voting result (opens in a new tab)
- Regularisation of appointment of Mr. Bidari Kotresh Anilkumar (DIN 06624790) as Executive Director of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 69.72% · promoters 100.00% · institutions 0.00% · other public 56.35%
To consider and approve Acquisition of Sushodha Institute of Gastroenterology Private Limited and approval of Material Related Party Transactions with Mr. Bidari Kotresh Anilkumar and Mr. Dhanaji Dattatray JadhavMoreLess
SpecialPromoters have an interest in it100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 35.51% · promoters 0.00% · institutions 0.00% · other public 51.19%
- Preferential issue of equity shares for consideration other than cash (Sushodha Institute of Gastroenterology Private Limited)Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 66.13% · promoters 100.00% · institutions 0.00% · other public 51.19%
Approval and Ratification of Revised Practising Chartered Accountants Certificate submitted pursuant to Regulation 45 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015 in connection with the Change of Name of the CompanyMoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 69.72% · promoters 100.00% · institutions 0.00% · other public 56.35%
- Shifting of the Registered Office of the Company from the State of Assam to the State of Maharashtra and consequential alteration of Clause II of the Memorandum of AssociationSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 69.72% · promoters 100.00% · institutions 0.00% · other public 56.35%
- Modification of lock- in period of the certain Shareholders of the companySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 66.13% · promoters 100.00% · institutions 0.00% · other public 51.19%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesMay 2025 | 5.63 | Business expansion, funding working capital requirements and general corporate purposes and for any other purpose as may be decided and approved by the Board. | 5.63 | 5.63 | No |